Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrocystic Changes”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)Ended earlyNCT03979508
What this trial is testing

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more
Mayo Clinic 26
Large-scale testing (Phase 3)UnknownNCT00237523
What this trial is testing

Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain

Who this might be right for
Fibrocystic Disease of BreastFibrocystic Changes of BreastFibrocystic Mastopathy+1 more
Symbollon Pharmaceuticals 175
Not applicableStudy completedNCT01052740
What this trial is testing

X-Ray Mammography Standard of Care Protocol

Who this might be right for
Breast CancerInvasive CarcinomaIn Situ Carcinoma+2 more
National Institutes of Health Clinical Center (CC) 108